Literature DB >> 26759464

Surgical Management of Liver Metastases From Colorectal Cancer.

Mashaal Dhir1, Aaron R Sasson2.   

Abstract

Surgical resection remains one of the major curative treatment options available to patients with colorectal liver metastases. Surgery and chemotherapy form the backbone of the treatment in patients with colorectal liver metastases. With more effective chemotherapy regimens being available, the optimal timing and sequencing of treatments are important. A multidisciplinary approach with the involvement of medical oncologists and surgical oncologists from the beginning is crucial. Identification of the clinical and molecular prognostic factors may help personalize the treatment approaches for these patients. This article provides an overview of the surgical management of colorectal liver metastases.
Copyright © 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2016        PMID: 26759464     DOI: 10.1200/JOP.2015.009407

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  14 in total

Review 1.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

Review 2.  Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).

Authors:  Hui-Chuan Sun; Jian Zhou; Zheng Wang; Xiufeng Liu; Qing Xie; Weidong Jia; Ming Zhao; Xinyu Bi; Gong Li; Xueli Bai; Yuan Ji; Li Xu; Xiao-Dong Zhu; Dousheng Bai; Yajin Chen; Yongjun Chen; Chaoliu Dai; Rongping Guo; Wenzhi Guo; Chunyi Hao; Tao Huang; Zhiyong Huang; Deyu Li; Gang Li; Tao Li; Xiangcheng Li; Guangming Li; Xiao Liang; Jingfeng Liu; Fubao Liu; Shichun Lu; Zheng Lu; Weifu Lv; Yilei Mao; Guoliang Shao; Yinghong Shi; Tianqiang Song; Guang Tan; Yunqiang Tang; Kaishan Tao; Chidan Wan; Guangyi Wang; Lu Wang; Shunxiang Wang; Tianfu Wen; Baocai Xing; Bangde Xiang; Sheng Yan; Dinghua Yang; Guowen Yin; Tao Yin; Zhenyu Yin; Zhengping Yu; Bixiang Zhang; Jialin Zhang; Shuijun Zhang; Ti Zhang; Yamin Zhang; Yubao Zhang; Aibin Zhang; Haitao Zhao; Ledu Zhou; Wu Zhang; Zhenyu Zhu; Shukui Qin; Feng Shen; Xiujun Cai; Gaojun Teng; Jianqiang Cai; Minshan Chen; Qiang Li; Lianxin Liu; Weilin Wang; Tingbo Liang; Jiahong Dong; Xiaoping Chen; Xuehao Wang; Shusen Zheng; Jia Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

3.  Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.

Authors:  Xiao-Dong Zhu; Cheng Huang; Ying-Hao Shen; Yuan Ji; Ning-Ling Ge; Xu-Dong Qu; Lingli Chen; Wen-Kai Shi; Mei-Ling Li; Jin-Jin Zhu; Chang-Jun Tan; Zhao-You Tang; Jian Zhou; Jia Fan; Hui-Chuan Sun
Journal:  Liver Cancer       Date:  2021-03-30       Impact factor: 11.740

4.  The Role of Radiotherapy in the Treatment of Retroperitoneal Lymph Node Metastases from Colorectal Cancer.

Authors:  Pei Shu; Ganlu Ouyang; Fang Wang; Jitao Zhou; Yali Shen; Zhiping Li; Xin Wang
Journal:  Cancer Manag Res       Date:  2020-09-23       Impact factor: 3.989

5.  Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.

Authors:  Georgios Antonios Margonis; Kazunari Sasaki; Yuhree Kim; Mario Samaha; Stefan Buettner; Neda Amini; Efstathios Antoniou; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-07-06       Impact factor: 3.452

6.  The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations.

Authors:  Rachel Wong; Jeanne Tie; Margaret Lee; Joshua Cohen; Yuxuan Wang; Lu Li; Stephen Ma; Michael Christie; Suzanne Kosmider; Cristian Tomasetti; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Peter Gibbs
Journal:  Int J Cancer       Date:  2019-01-24       Impact factor: 7.396

Review 7.  The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer.

Authors:  Chunye Zhang; Ming Yang; Aaron C Ericsson
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244

8.  Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.

Authors:  Jason M Foster; Richard Sleightholm; Asish Patel; Valerie Shostrom; Bradley Hall; Beth Neilsen; David Bartlett; Lynette Smith
Journal:  JAMA Netw Open       Date:  2019-01-04

Review 9.  Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application.

Authors:  Girolamo Ranieri; Mariarita Laforgia; Patrizia Nardulli; Simona Ferraiuolo; Pasquale Molinari; Ilaria Marech; Cosmo Damiano Gadaleta
Journal:  Cancers (Basel)       Date:  2019-01-24       Impact factor: 6.639

10.  Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis.

Authors:  Yiping He; Xiaoji Ma; Ke Chen; Fangqi Liu; Sanjun Cai; Han Han-Zhang; Ting Hou; Jianxing Xiang; Junjie Peng
Journal:  Cancer Manag Res       Date:  2020-03-04       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.